Literature DB >> 20110378

Gbetagamma signaling promotes breast cancer cell migration and invasion.

Joseph K Kirui1, Yan Xie, Dennis W Wolff, Haihong Jiang, Peter W Abel, Yaping Tu.   

Abstract

Signaling through G protein-coupled receptors (GPCRs) promotes breast cancer metastasis. G proteins convey GPCR signals by dissociating into Galpha and Gbetagamma subunits. The aim of the present study was to determine whether blockade of Gbetagamma signaling suppresses breast cancer cell migration and invasion, which are critical components of metastasis. Conditioned media (CM) of NIH-3T3 fibroblasts are widely used as chemoattractants in in vitro cancer metastasis studies. Expression of a Gbetagamma scavenger peptide attenuated NIH-3T3 CM-induced migration and invasion of both metastatic breast cancer MDA-MB-231 and MDA-MB-436 cells by 40 to 50% without effects on cell viability. Migration and invasion of cells in response to NIH-3T3 CM were also blocked by 8-(4,5,6-trihydroxy-3-oxo-3H-xanthen-9-yl)-1-naph-thalene-carboxylic acid) (M119K), a Gbetagamma inhibitor, with maximum inhibition exceeding 80% and half-maximal inhibitory concentration (IC50) values of 1 to 2 microM. M119K also attenuated Rac-dependent formation of lamellipodia, a key structure required for metastasis. Constitutively active Rac1 rescued Gbetagamma blockade-mediated inhibition of breast cancer cell migration, whereas dominant negative Rac1 inhibited cell migration similar to Gbetagamma blockade. Furthermore, M119K suppressed Gi protein-coupled CXC chemokine receptor 4 (CXCR4)-dependent MDA-MB-231 cell migration by 80% with an IC50 value of 1 microM, whereas tyrosine kinase receptor-dependent cell migration was significantly less inhibited. However, CXCR4-dependent inhibition of adenylyl cyclase, a Gialpha-mediated response in MDA-MB-231 cells, was not blocked by M119K but was blocked by pertussis toxin, which selectively inactivates Gialpha. This report is the first to directly demonstrate the role of Gbetagamma in cancer cell migration and invasion and suggests that targeting Gbetagamma signaling pathways may provide a novel strategy for suppressing breast cancer metastasis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20110378      PMCID: PMC2872950          DOI: 10.1124/jpet.109.164814

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  39 in total

Review 1.  Chemotaxis: signalling the way forward.

Authors:  Peter J M Van Haastert; Peter N Devreotes
Journal:  Nat Rev Mol Cell Biol       Date:  2004-08       Impact factor: 94.444

2.  Attenuation of Gi- and Gq-mediated signaling by expression of RGS4 or GAIP in mammalian cells.

Authors:  C Huang; J R Hepler; A G Gilman; S M Mumby
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

3.  RGS proteins reconstitute the rapid gating kinetics of gbetagamma-activated inwardly rectifying K+ channels.

Authors:  C A Doupnik; N Davidson; H A Lester; P Kofuji
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

Review 4.  G proteins: transducers of receptor-generated signals.

Authors:  A G Gilman
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

Review 5.  The active role of beta gamma in signal transduction.

Authors:  P C Sternweis
Journal:  Curr Opin Cell Biol       Date:  1994-04       Impact factor: 8.382

6.  Receptors induce chemotaxis by releasing the betagamma subunit of Gi, not by activating Gq or Gs.

Authors:  E R Neptune; H R Bourne
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

7.  Targeting Gbetagamma signaling to inhibit prostate tumor formation and growth.

Authors:  Angela L Bookout; Amanda E Finney; Rishu Guo; Karsten Peppel; Walter J Koch; Yehia Daaka
Journal:  J Biol Chem       Date:  2003-07-17       Impact factor: 5.157

8.  Directional sensing requires G beta gamma-mediated PAK1 and PIX alpha-dependent activation of Cdc42.

Authors:  Zhong Li; Michael Hannigan; Zhicheng Mo; Bo Liu; Wei Lu; Yue Wu; Alan V Smrcka; Guanqing Wu; Lin Li; Mingyao Liu; Chi-Kuang Huang; Dianqing Wu
Journal:  Cell       Date:  2003-07-25       Impact factor: 41.582

9.  Distinct pathways of Gi- and Gq-mediated mitogen-activated protein kinase activation.

Authors:  B E Hawes; T van Biesen; W J Koch; L M Luttrell; R J Lefkowitz
Journal:  J Biol Chem       Date:  1995-07-21       Impact factor: 5.157

10.  Betagamma subunits mediate the NPY enhancement of ATP-stimulated inositol phosphate formation.

Authors:  Xinying Li; Tsuneya Ikezu; Terry D Hexum
Journal:  Peptides       Date:  2004-02       Impact factor: 3.750

View more
  38 in total

1.  Phosphoinositide 3-kinase gamma regulates airway smooth muscle contraction by modulating calcium oscillations.

Authors:  Haihong Jiang; Peter W Abel; Myron L Toews; Caishu Deng; Thomas B Casale; Yan Xie; Yaping Tu
Journal:  J Pharmacol Exp Ther       Date:  2010-05-25       Impact factor: 4.030

2.  Nitric oxide functions in stromal cell-derived factor-1-induced cytoskeleton changes and the migration of Jurkat cells.

Authors:  Jixian Luo; Dan Wei; Dingyun Li; Lan Wang
Journal:  Oncol Lett       Date:  2018-09-11       Impact factor: 2.967

Review 3.  Understanding molecular recognition by G protein βγ subunits on the path to pharmacological targeting.

Authors:  Yuan Lin; Alan V Smrcka
Journal:  Mol Pharmacol       Date:  2011-07-07       Impact factor: 4.436

4.  Statins Perturb Gβγ Signaling and Cell Behavior in a Gγ Subtype Dependent Manner.

Authors:  Mithila Tennakoon; Dinesh Kankanamge; Kanishka Senarath; Zehra Fasih; Ajith Karunarathne
Journal:  Mol Pharmacol       Date:  2019-02-14       Impact factor: 4.436

5.  Inhibition of the ethanol-induced potentiation of α1 glycine receptor by a small peptide that interferes with Gβγ binding.

Authors:  Loreto San Martin; Fabian Cerda; Veronica Jimenez; Jorge Fuentealba; Braulio Muñoz; Luis G Aguayo; Leonardo Guzman
Journal:  J Biol Chem       Date:  2012-10-03       Impact factor: 5.157

6.  Characterization of EHop-016, novel small molecule inhibitor of Rac GTPase.

Authors:  Brenda L Montalvo-Ortiz; Linette Castillo-Pichardo; Eliud Hernández; Tessa Humphries-Bickley; Alina De la Mota-Peynado; Luis A Cubano; Cornelis P Vlaar; Suranganie Dharmawardhane
Journal:  J Biol Chem       Date:  2012-03-01       Impact factor: 5.157

7.  Novel role of Giα2 in cell migration: Downstream of PI3-kinase-AKT and Rac1 in prostate cancer cells.

Authors:  Silvia Caggia; HimaBindu Chunduri; Ana C Millena; Jonathan N Perkins; Smrruthi V Venugopal; BaoHan T Vo; Chunliang Li; Yaping Tu; Shafiq A Khan
Journal:  J Cell Physiol       Date:  2018-08-04       Impact factor: 6.384

8.  NO triggers RGS4 degradation to coordinate angiogenesis and cardiomyocyte growth.

Authors:  Irina M Jaba; Zhen W Zhuang; Na Li; Yifeng Jiang; Kathleen A Martin; Albert J Sinusas; Xenophon Papademetris; Michael Simons; William C Sessa; Lawrence H Young; Daniela Tirziu
Journal:  J Clin Invest       Date:  2013-04       Impact factor: 14.808

9.  Defective chemokine signal integration in leukocytes lacking activator of G protein signaling 3 (AGS3).

Authors:  Melissa Branham-O'Connor; William G Robichaux; Xian-Kui Zhang; Hyeseon Cho; John H Kehrl; Stephen M Lanier; Joe B Blumer
Journal:  J Biol Chem       Date:  2014-02-26       Impact factor: 5.157

10.  The interplay between G protein-coupled receptor kinase 2 (GRK2) and histone deacetylase 6 (HDAC6) at the crossroads of epithelial cell motility.

Authors:  Vanesa Lafarga; Federico Mayor; Petronila Penela
Journal:  Cell Adh Migr       Date:  2012-10-17       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.